| Prostatic Neoplasms |
NCT01581749: Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer |
|
|
| Recruiting | 4 | 50 | US | "TrueBeam" stereotactic body radiosurgery | Albert DeNittis | Prostate Neoplasms | 12/17 | 12/22 | | |
| Active, not recruiting | 3 | 2205 | Europe, Canada, RoW | Prostatectomy, Conventionally Fractionated Prostate Radiotherapy, Prostate SBRT | Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Sutton, Surrey, UK | Prostate Cancer | 12/25 | 12/27 | | |
NCT01317043: A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy |
|
|
| Recruiting | 2 | 76 | US | Samarium/IMRT, Samarium ethylenediaminetetramethylenephosphonate | Sentara Norfolk General Hospital, RTOG | Non-metastatic Prostate Cancer, Post Radical Prostatectomy | | | | |
| Completed | 2 | 63 | RoW | Dendritic Cells DCVAC/PCa, Leuprolide acetate, Lupron, Goserelin Acetate, Zoladex | SOTIO a.s., Ascend Biopharmaceuticals Ltd | Basal Cell Carcinoma, Basal Cell Nevus Syndrome (BCNS) | 12/15 | 06/16 | | |
NCT00003915: Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer |
|
|
| Active, not recruiting | 2 | 63 | US | bicalutamide, docetaxel, estramustine phosphate sodium, leuprolide acetate | University of Massachusetts, Worcester | Prostate Cancer | 02/18 | 02/18 | | |
NCT02040610: Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer |
|
|
| Recruiting | 2 | 235 | US | Hypofractionated Proton Therapy, Proton Therapy | Provision Center for Proton Therapy, Center for Biomedical Research, LLC | Prostate Cancer | 12/19 | 12/25 | | |
NCT01913106: HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
|
|
| Recruiting | 1/2 | 25 | US | HSV-tk +Valacyclovir in Combination with Brachytherapy, IND 13567 | The Methodist Hospital Research Institute | Prostatic Neoplasms | 12/18 | 12/28 | | |
NCT01705028: Assessment of Amide-Proton-Transfer MRI in Prostate Cancer |
|
|
| Recruiting | 1 | 208 | US | MR Imaging of the prostate using Amide-Proton-Transfer, CEST MRI of APT of the prostate | Michael Knopp, National Cancer Institute (NCI) | Prostate Cancer | 12/15 | 06/16 | | |
NCT00636259: Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer |
|
|
| No Longer Available | N/A | | US | Bicalutamide (Casodex) | AstraZeneca | Adenocarcinoma of the Prostate | | | | |
TADS, NCT01007825: Testosterone-Guided Schedule of Androgen Deprivation Therapy (ADT) as an Alternative to A Fixed Schedule In Management Of Prostate Cancer |
|
|
| Not yet recruiting | N/A | 100 | NA | | University Health Network, Toronto | Prostate Cancer | 10/10 | 03/11 | | |
NCT01516762: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases |
|
|
| No Longer Available | N/A | | US | Radium-223 dichloride (BAY88-8223) | Bayer | Prostatic Neoplasms | | | | |
|
NCT01777061: Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan |
|
|
| No Longer Available | N/A | | US | [11C]Acetate, carbon-11 acetate [[11C]acetate], sodium acetate [11C]Acetate injection | Wendell Yap, MD, University of Kansas Medical Center | Prostate Cancer | | | | |
NCT01834209: A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| No Longer Available | N/A | | RoW | Abiraterone acetate, Prednisone or prednisolone | Janssen Research & Development, LLC | Prostate Neoplasms | | | | |
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
|
|
| Recruiting | N/A | 1000 | RoW | | Meir Medical Center | Kidney Cancer, Prostate Cancer, Bladder Cancer | 08/19 | 08/25 | | |
| Recruiting | N/A | 354 | Europe | questionnaire administration, assessment of therapy complications, high-intensity focused ultrasound ablation, multiparametric magnetic resonance imaging, quality-of-life assessment, transperineal prostate biopsy, transrectal prostate biopsy | University College, London | Male Erectile Disorder, Prostate Cancer, Therapy-related Toxicity, Urinary Incontinence | 12/28 | 06/29 | | |